Gastrointestinal Special Issue | CURE

Looking Within: Exploring Genomic Testing for GI Cancers

April 05, 2018

Article

Features

Genomic testing of gastrointestinal tumors can be essential to proper treatment.

Every Patient Who Has a GI Cancer Should Be Tested for MSI-High Status

April 05, 2018

Article

Editor's Page

With immunotherapy continuing to command headlines in the world of oncology, it’s no surprise that patients with a variety of cancers wonder whether the strategy might help them address and overcome their illnesses.

A New Year Brings Treatment Options and Hope for Patients With Gastrointestinal Cancers

April 05, 2018

Article

From the Chairman

It's amazing what a new year can bring.

A Major Turnaround for Liver Cancer

April 04, 2018

Article

Features

After 10 years without a new drug for liver cancer, two approvals and a promising pipeline are changing the landscape.

All Over the Map When It Comes to Survivorship

April 04, 2018

Article

Features

Every survivor of a gastrointestinal cancer has unique follow-up needs. A ‘road map’ for this process can help.

Beneath the Surface: Advancing Treatment for Cholangiocarcinoma

March 31, 2018

Article

Features

Progress in cholangiocarcinoma treatment was long stalled, but now scientists are identifying genetic drivers likely to respond to novel drugs.

Paying it Forward

March 30, 2018

Article

Features

Funded posthumously by a "Jeopardy!" winner, an immunotherapy research project is under way.

On the Double: Improving Survival Rates in Pancreatic Cancer

March 25, 2018

Article

Speaking Out

A leader of the Pancreatic Cancer Action Network, which aims to double survival rates by 2020, outlines treatment strategies that could lead to success.

Chemo Regimen Helps Control Locally Advanced Pancreatic Cancer

March 23, 2018

Article

Conference Coverage

“Disease control is key in our patients with locally advanced disease, as it may lead to opportunities for additional treatment interventions, including radiotherapy, or even, in some favorable cases, surgical resection,” said lead study author Pascal Hammel, M.D., Ph.D.

Immunotherapy After Targeted Drug Shows Promise in Advanced Liver Cancer

March 22, 2018

Article

Conference Coverage

Treatment with the PD-1 inhibitor Keytruda (pembrolizuumab) elicited promising progression-free survival (PFS) and overall survival (OS) results in patients with advanced hepatocellular carcinoma (HCC) who received previous treatment with Nexavar (sorafenib), according to phase 2 findings.

Cabometyx Improves Survival in Patients With Advanced Hepatocellular Carcinoma

March 21, 2018

Article

Conference Coverage

“Patients with advanced hepatocellular carcinoma often have a poor prognosis and limited treatment options following prior systemic therapy,” lead investigator Ghassan K. Abou-Alfa, M.D.

High Expectations for Immunotherapy in GI Cancers

March 18, 2018

Article

Features

Immunotherapy may play a growing role in treating gastrointestinal cancers categorized as MSI-high.

A Cut Above Open Surgery

March 17, 2018

Article

Features

Laparoscopy proves safer than open surgery and costs less than robotic resection for colorectal cancer.